A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and

Gayle M Smythe1, Joshua C Eby, Marie-Helene Disatnik

  • 1Department of Neurology and Neurological Science, Stanford University School of Medicine, Stanford, California 94305-5235, USA.

Journal of Cell Science
|November 6, 2003
PubMed

Insights

A caveolin-3 mutation linked to limb girdle muscular dystrophy type 1C disrupts Src signaling and caveolae function, leading to muscle cell apoptosis and potential muscle degeneration.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Caveolins are essential membrane proteins forming caveolae, which scaffold signaling complexes.
  • Caveolin-3 is crucial in skeletal muscle; mutations cause limb girdle muscular dystrophy type 1C (LGMD-1C).
  • The TFT mutation in caveolin-3 leads to protein loss and reduced caveolae formation.

Purpose of the Study:

  • To investigate the functional consequences of the TFT caveolin-3 mutation on cellular signaling and caveolae function.
  • To elucidate the impact of this mutation on Src tyrosine kinase localization and activation.
  • To determine if the TFT mutation contributes to muscle cell apoptosis.

Main Methods:

  • Studied post-mitotic skeletal myotubes expressing the TFT caveolin-3 mutation.
  • Assessed caveolin-3 localization to the plasma membrane and lipid rafts.
  • Analyzed Src binding to caveolin-3, Src targeting to lipid rafts, and Src activation.
  • Quantified apoptosis incidence in myotubes.

Main Results:

  • The TFT mutation severely impaired caveolin-3 localization and caveolar function.
  • Src binding to caveolin-3 was reduced, and Src targeting to lipid rafts was diminished.
  • Abnormal Src accumulation occurred near the nucleus, alongside elevated Src activation and increased apoptosis.

Conclusions:

  • LGMD-1C-associated caveolin-3 mutations disrupt caveolae-mediated signaling pathways.
  • Altered Src signaling and increased apoptosis in muscle cells may underlie muscle degeneration in LGMD-1C.
  • The TFT mutation provides a model for understanding disease pathogenesis.